- Home
- SSTI vs PMVP Comparison
SSTI vs PMVP Comparison
Compare SSTI & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSTI | PMVP |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.3M | 79.5M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SSTI | PMVP |
|---|---|---|
| Price | $6.44 | $1.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $15.00 | $5.00 |
| AVG Volume (30 Days) | 176.6K | ★ 839.1K |
| Earning Date | 03-03-2026 | 03-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $34,753,000.00 | N/A |
| Revenue This Year | $11.93 | N/A |
| Revenue Next Year | $9.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 46.25 | N/A |
| 52 Week Low | $5.78 | $0.82 |
| 52 Week High | $17.38 | $1.88 |
Technical Indicators
Market Signals| Indicator | SSTI | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 52.99 |
| Support Level | $6.03 | $1.32 |
| Resistance Level | $7.96 | $1.48 |
| Average True Range (ATR) | 0.51 | 0.09 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 17.65 | 1.36 |
Price Performance
Historical ComparisonAbout SSTI SoundThinking Inc.
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.